1429 related articles for article (PubMed ID: 19373629)
1. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
2. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
4. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs.
Sawicki GS; Vilk Y; Schatz M; Kleinman K; Abrams A; Madden J
J Asthma; 2010 Jun; 47(5):574-80. PubMed ID: 20560831
[TBL] [Abstract][Full Text] [Related]
5. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
[TBL] [Abstract][Full Text] [Related]
6. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
7. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
Colice GL; Yu AP; Ivanova JI; Hsieh M; Birnbaum HG; Lage MJ; Brewster C
J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
[TBL] [Abstract][Full Text] [Related]
8. Asthma prevalence, cost, and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population.
Piecoro LT; Potoski M; Talbert JC; Doherty DE
Health Serv Res; 2001 Jun; 36(2):357-71. PubMed ID: 11409817
[TBL] [Abstract][Full Text] [Related]
9. Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate.
Lage MJ; Gross GN; Brewster C; Spalitto A
Adv Ther; 2009 Aug; 26(8):762-75. PubMed ID: 19669630
[TBL] [Abstract][Full Text] [Related]
10. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE; Hagiwara M; Stanford RH; Stempel DA
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[TBL] [Abstract][Full Text] [Related]
11. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
12. Asthma costs and utilization in a managed care organization.
Zeiger RS; Hay JW; Contreras R; Chen W; Quinn VP; Seal B; Schatz M
J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory medication adherence and cost and utilization of asthma care in a commercially insured population.
Mattke S; Martorell F; Hong SY; Sharma P; Cuellar A; Lurie N
J Asthma; 2010 Apr; 47(3):323-9. PubMed ID: 20394518
[TBL] [Abstract][Full Text] [Related]
14. The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organization.
Schatz M; Camargo CA
Ann Allergy Asthma Immunol; 2003 Dec; 91(6):553-8. PubMed ID: 14700439
[TBL] [Abstract][Full Text] [Related]
15. Ratio of controller to total asthma medications: determinants of the measure.
Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M
Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912
[TBL] [Abstract][Full Text] [Related]
16. Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.
Campbell JD; Allen-Ramey F; Sajjan SG; Maiese EM; Sullivan SD
Am J Manag Care; 2011 Oct; 17(10):703-10. PubMed ID: 22106463
[TBL] [Abstract][Full Text] [Related]
17. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
18. [Predictive factors associated with severity of asthma exacerbations].
Atiş S; Kaplan ES; Ozge C; Bayindir S
Tuberk Toraks; 2008; 56(2):187-96. PubMed ID: 18701979
[TBL] [Abstract][Full Text] [Related]
19. Relationship between pediatric primary provider visits and acute asthma ED visits.
Smith SR; Wakefield DB; Cloutier MM
Pediatr Pulmonol; 2007 Nov; 42(11):1041-7. PubMed ID: 17902163
[TBL] [Abstract][Full Text] [Related]
20. Urban minority children with asthma: substantial morbidity, compromised quality and access to specialists, and the importance of poverty and specialty care.
Flores G; Snowden-Bridon C; Torres S; Perez R; Walter T; Brotanek J; Lin H; Tomany-Korman S
J Asthma; 2009 May; 46(4):392-8. PubMed ID: 19484676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
